(ShareCast News) - EKF Diagnostics shares rose on Wednesday as Panmure Gordon reiterated a 'buy' rating and target price of 14p after an upbeat trading update. In a first half trading update, EKF said sales and adjusted EBITDA are ahead of market expectations for the six months ended 30 June 2016.
Read more(ShareCast News) - Harwood Capital, acting as investment manager on behalf of North Atlantic Smaller Companies Investment Trust PLC, picked up another large batch of shares in EKF Diagnostics. Christoper Mills, who was named to the post of non-executive chairman at the global point-of-care medical d
Read more(ShareCast News) - Ron Zwanziger has resigned as non-executive director of EKF Diagnostics with immediate effect. The AIM-listed point-of-care business confirmed the news in a statement on Monday. Last week, EKF appointed Christopher Mills as non-executive chairman with immediate effect. Mills is c
Read more